Results 171 to 180 of about 30,778 (256)

Development of a Novel Engineered Antibody Format for PSMA-Targeted Radionuclide Therapy. [PDF]

Mol Pharm
Fletcher NL, Houston ZH, Chandler PG, Yan E, Holgate R, Wheatcroft M, Thurecht KJ.   +6 more
europepmc   +1 more source

²¹¹At on gold nanoparticles for targeted radionuclide therapy application

Jeffrey Tanudji, Hideaki Kasai, Michio Okada, Tetsuo Ogawa, Susan Meñez Aspera, Hiroshi Nakanishi   +5 more
openalex   +2 more sources

On the reduction of imaging time-points for dosimetry in radionuclide therapy. [PDF]

EJNMMI Phys
Gustafsson J, Taprogge J.
europepmc   +1 more source

Somatostatin receptor expression for peptide receptor radionuclide therapy in Japanese patients with recurrent or metastatic differentiated thyroid cancer [PDF]

Shiro Watanabe, Kenji Hirata, Junki Takenaka, Yamato Munakata, Kazuaki Mori, N. Wakabayashi, Hiroto Koga, Kohsuke Kudo   +7 more
openalex   +1 more source

Tumor sink effect on melanin-ligand [¹³¹I]ICF01012 in melanoma and its implications for targeted radionuclide therapy. [PDF]

EJNMMI Res
Jouberton E, Besse S, Billoux T, Auzeloux P, Schmitt S, Chezal JM, Sas N, Noirault L, Auriol M, Levesque S, Delmas M, Chaussin B, Chautard E, Miot-Noirault E, Rouanet J, Cachin F.   +15 more
europepmc   +1 more source

Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023 [PDF]

Gianpaolo di Santo, Giulia Santo, Anna Sviridenko, Irene Virgolini   +3 more
openalex   +1 more source

Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy. [PDF]

Eur J Nucl Med Mol Imaging
Mendes F, Terry SYA, Spiegelberg D, Cornelissen B, Bolcaen J, Nonnekens J, European Working group of Radiobiology of Molecular Radionuclide Therapy.   +6 more
europepmc   +1 more source

Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors. [PDF]

Pharmaceuticals (Basel)
Leupe H, Cauwenbergh M, Cleeren F, Dekervel J, Verslype C, Deroose CM.   +5 more
europepmc   +1 more source

131I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy

, 2019
Ning Sun, Lingzhou Zhao, Zhu J, Li Y, Na‐Young Song, Yan Xing, Wenli Qiao, He Huang, Jinhua Zhao   +8 more
openalex   +1 more source

Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years. [PDF]

Theranostics
Zhang J, Mensel B, Baum RP.
europepmc   +1 more source